Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review

Boehringer Ingelheim expands its business with Biosimilars

Boehringer Ingelheim headquarters

As part of its corporate strategy Boehringer Ingelheim is to establish a new separate business for the development and commercialisation of its own biosimilars.

The move will leverage Boehringer Ingelheim's capabilities in product development, supply and clinical expertise...

Read more >>

More pharmaceutical & life science news:

BIBF 1120 in patients with metastatic colorectal cancer as effective as bevacizumab with less serious adverse events
Patients with metastatic colorectal cancer (mCRC) receiving BIBF 1120 as first-line treatment in combination with mFOLFOX6 showed a median progression-free survival of 10.6 months which was equivalent to bevacizumab plus mFOLFOX6 in a randomised two arm phase II study enrolling a total of 126 patients...

Novartis receives approval in Japan for two innovative therapies, Gilenya® in MS and Ilaris® in CAPS
Novartis has received regulatory approval in Japan for once-daily Gilenya (fingolimod)...

New data shows potential of respiratory portfolio to help COPD patients maintain active and productive lives
Novartis has presented new Phase III data at the ERS congress...

ALIMTA helped keep most common form of lung cancer at bay in elderly patients
New data from PARAMOUNT study shows benefit in this hard-to-treat population...

Afinitor® helps women with advanced breast cancer live longer without their disease progressing
Afinitor® more than doubled the time women lived without tumor growth...

ALIMTA receives positive opinion from CHMP
CHMP has issued a positive opinion for the use of ALIMTA® as continuation maintenance therapy for deadly form of lung cancer...

AstraZeneca announces first approval of FASLODEX™ (fulvestrant) in Japan
AstraZeneca announced that FASLODEX™ (fulvestrant) has received regulatory approval...

Roche’s investigational medicine T-DM1 shows improvement in progression-free survival compared to standard of care in HER2-positive metastatic breast cancer
Phase II study TDM4450g results announced...

KOMBOGLYZE™ receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
KOMBOGLYZE™ receives a positive opinion from CHMP...

Novartis gains positive CHMP opinion for Rasitrio®
The CHMP adopted a positive opinion for Rasitrio® for the treatment of high blood pressure...

Novartis drug Afinitor® effective in patients with non-cancerous kidney tumors associated with TSC in Phase III trial
A Phase III study of Afinitor® (everolimus) tablets* met its primary endpoint of best overall angiomyolipoma response rate...

European CHMP adopts positive opinion for Eviplera(R)
CHMP, has adopted a positive opinion on the company's Marketing Authorisation Application for the once-daily single-tablet regimen, Eviplera(R)...

Positive opinion on the usage of Levemir® (insulin detemir) as add-on therapy to Victoza® (liraglutide) in people with type 2 diabetes
CHMP has adopted a positive opinion on the usage of Novo Nordisk’s basal insulin analogue, Levemir®...

Events, conferences & exhibitions:

7th Annual Achieving Quality & Process Exellence in the Pharmaceutical Industry
5 - 6 October 2011, Barcelona, Spain

Pharmaceutical m-Health
10 - 11 October 2011, London, UK

DIA 5th Annual Clinical Forum
10 - 12 October 2011 Basel, Switzerland

BIOTECHNICA
11 - 13 October 2011, Hannover, Germany

PDA’s 6th Annual Global Conference on Pharmaceutical Microbiology
17 - 21 October 2011, Bethesda, USA

BioProduction 2011
19 - 20 October 2011, Berlin, Germany

Process Validation for Drugs and Biologics
26 - 27 October 2011, Berlin, Germany

BIA Research and Development Conference
27 October 2011, London, UK

European Pharmaceutical Pricing & Reimbursement
31 October - 1 November 2011, Basel, Switzerland

BIT’s 1st Annual Symposium of Drug Delivery Systems 2011
3 - 5 November 2011 Liaoning, China

BIT’s 9th Annual Congress of International Drug Discovery Science and Technology
3 - 6 November 2011, Shenzden, China

BIT’s 2nd Annual World Congress of NanoMedicine 2011
3 - 6 November 2011, Guangdong, China

IFPAC 2012
22 - 25 January 2012 Baltimore, USA

Particle Monitoring for ISO 21501 Compliant Pharmaceutical Manufacturing from HACH LANGE

MET ONE Facility Monitoring Systems from HACH LANGE provide paperless compliance solutions for particle counting in your Grade “A” sterile areas. With new innovative designs specifically tailored to address the requirements of the Pharmaceutical industry, MET ONE particle counters feature full ISO 21501 compliance in advance of ISO 14644 standard adoption for all calibration parameters. Based on open-architecture communications, they integrate easily with your preferred systems. To make manual monitoring more efficient, MET ONE portable counters feature testing Wizards, automatic and paperless data transfer compliant with 21 CFR Part 11. All our counters support 0.5 μm and 5.0 μm size channels as per regulatory requirements.

To help build your FMS System HACH LANGE offer:

  • Scalable software solutions for data management & reporting
  • Compliance Services to assist with SOP development & validation documentation
  • System Development for project management , installation & commissioning
  • Environmental Sensors like pressure, air velocity & temp/RH to complete the system

As the leading provider of particle monitoring systems for Pharmaceutical Manufacturing since 1987, MET ONE from HACH LANGE has the most experience meeting regulatory requirements. HACH LANGE are Compliance Experts and will help you stay abreast of current regulations as well as help guide your choice of FMS Monitoring Solutions.

Click here for more information >>

Company directory

Our new look directory includes the following Premium listings:

- Almac
- BD Diagnostics
Bio-Optronics, Inc.
- bioMérieux
BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- Cellular Dynamics International, Inc.
CI Precision
- Cisbio Bioassays
- Colder Products Company
- Comark Instruments
DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Until 30 September you can save 20% when you create a Premium listing for your company - just enter the discount code LAUNCH during sign-up:

Add your company >>


Join European Pharmaceutical Review on LinkedIn


Follow European Pharmaceutical Review on Twitter


Like European Pharmaceutical Review on Facebook